Intel Collect bonds: yield 25.9% and VDO market https://ymaho.com/intel-collect-bonds-yield-25-9-and-vdo-market
Intel Collect placed a issue for 1 billion rubles with a coupon of 23.25% and YTM of 25.9%. Demand exceeded supply. Find out why investors are hunting for VDO with a premium to the Central Bank rate of 11 percentage points.
Intel and Qualcomm stocks: growth on chips and contracts https://ymaho.com/intel-and-qualcomm-stocks-growth-on-chips-and-contracts
Analysis of the reasons for the rally of Intel and Qualcomm stocks in May 2026: Apple agreement, AI contracts and a new CPU supercycle. Find out who wins and how to profit from it.
EU Court Overturns Intel €1.06 Billion Fine: Consequences https://ymaho.com/eu-court-overturns-intel-1-06-billion-fine-consequences
EU Court Overturns Intel €1.06 Billion Fine but Confirms Violations. Analysis of the timeline, precedent for antitrust cases, and consequences for the chip market. Read more.
Intellia CRISPR therapy: FDA filing for lonvo-z for HAE https://ymaho.com/intellia-crispr-therapy-fda-filing-for-lonvo-z-for-hae
Intellia has filed the world's first application for an in vivo CRISPR therapy, lonvo-z, for hereditary angioedema (HAE). 87% reduction in attacks, 62% attack-free. Risk, market, and forecast analysis. Read.
Intellia CRISPR therapy: phase 3 data on edema — breakthrough https://ymaho.com/intellia-crispr-therapy-phase-3-data-on-edema-breakthrough
Intellia presented long-awaited phase III data of CRISPR therapy lonvo-z for hereditary angioedema: 87% reduction in attacks, 62% of patients attack-free. Learn about the breakthrough in in vivo genome editing.
CRISPR Therapy HAE: Phase 3 Data from Intellia at EAACI 2026 https://ymaho.com/crispr-therapy-hae-phase-3-data-from-intellia-at-eaaci-2026
Intellia presented the long-awaited results of phase 3 of CRISPR therapy lonvoguran ziclumeran for hereditary angioedema. Reduction of attacks by 87%, 62% of patients without therapy. Learn more.
Apple and Intel chip manufacturing deal in the US: implications https://ymaho.com/apple-and-intel-chip-manufacturing-deal-in-the-us-implications
Analysis of the Apple and Intel chip development and manufacturing deal in the US. Who wins, what will change for consumers, and market forecasts. Read the full review.
Emotional Intelligence in Hair Care: Shower Therapy 2026 https://ymaho.com/emotional-intelligence-in-hair-care-shower-therapy-2026
53% of buyers choose shampoos for healing, not effect. How brands sell relaxation and replace the clinic with the forest. Read the trend analysis.
Emotional Intelligence: What It Is and How to Develop It | Complete Guide https://ymaho.com/emotional-intelligence-what-it-is-and-how-to-develop-it-complete-guide
What is emotional intelligence and how to develop it? 4 components, 5 steps, and self-regulation techniques. Develop EQ and improve relationships. Read now!
Purchase of Intel Citadel: Ken Griffin's bet on 12 million shares https://ymaho.com/purchase-of-intel-citadel-ken-griffin-s-bet-on-12-million-shares
Ken Griffin's Citadel bought 12 million Intel (INTC) shares and reduced its stake in AMD. Analysis of the 13F report, hidden factors, and forecasts. Read more.